Patents

US 12637522 B2: Monoclonal antibodies against BCMA

Granted
2026-05-26
Filed
2022-11-21 application 18057566
Type
Utility · 33 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The invention relates to new antibodies against BCMA, their manufacture and use.

Source: PTBLXML, file of 2026-05-26 (ipgb20260526.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Bristol-Myers Squibb Company 1,812 patentsUS company or organizationPrinceton, NJBRISTOL MYERS SQUIBB CO SEC filer FUZZY low confidence: same name (legal endings aside), one of each nationallyPTBLXML, file of 2026-05-26

Inventors

InventorPlacePatentsPerson pageSource
Minh Diem VuWollerau, CH8PTBLXML, file of 2026-05-26
Klaus StreinWeinheim, DE10PTBLXML, file of 2026-05-26
Oliver AstBassersdorf, CH19PTBLXML, file of 2026-05-26
Marina BacacZurich, CHPTBLXML, file of 2026-05-26
Camille DelonOberengstingen, CHPTBLXML, file of 2026-05-26
Lydia Jasmin HanischBirmensdorf, CHPTBLXML, file of 2026-05-26
Anne Freimoser-GrundschoberZurich, CH26PTBLXML, file of 2026-05-26
Christian KleinBonstetten, CH155PTBLXML, file of 2026-05-26
Ekkehard MoessnerKreuzlingen, CH100PTBLXML, file of 2026-05-26
Samuel MoserRotkreuz, CH9PTBLXML, file of 2026-05-26
Pablo UmanaWollerau, CH132PTBLXML, file of 2026-05-26
Tina WeinzierlSchlieren, CHPTBLXML, file of 2026-05-26

CPC categories

SubclassCategoryFirst groupSource
C07KPeptidesC07K16/468PTBLXML, file of 2026-05-26
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P35/02PTBLXML, file of 2026-05-26

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2024-04-12Assignment
Nunc pro tunc assignment
ENGMAB SÀRL signed 2021-12-10ENGMAB BETA HOLDINGS LLC WILMINGTON, DE67096/445PASDL, file of 2026-10-15
2024-04-12Assignment
Nunc pro tunc assignment
ENGMAB BETA HOLDINGS LLC signed 2021-12-13BRISTOL-MYERS SQUIBB COMPANY PRINCETON, NJ67096/402PASDL, file of 2026-10-15
2024-04-12Assignment
Assignment of assignor's interest
VU, MINH DIEM signed 2016-07-28
STREIN, KLAUS signed 2016-07-28
ENGMAB AG WILEN67091/373PASDL, file of 2026-10-15
2024-04-12Name change
Change of name
ENGMAB AG signed 2016-12-22ENGMAB SÀRL BOUDRY67091/368PASDL, file of 2026-10-15
2024-04-12Assignment
Assignment of assignor's interest
F. HOFFMANN-LA ROCHE AG signed 2016-03-23ENGMAB AG WILEN67091/365PASDL, file of 2026-10-15
2024-04-12Assignment
Assignment of assignor's interest
ROCHE GLYCART AG signed 2016-03-22F. HOFFMANN-LA ROCHE AG BASEL67091/362PASDL, file of 2026-10-15
2024-04-12Assignment
Assignment of assignor's interest
AST, OLIVER signed 2016-02-23
BACAC, MARINA signed 2016-02-19
DELON, CAMILLE signed 2016-02-23
DUERNER, LYDIA JASMIN signed 2016-02-22
FREIMOSER-GRUNDSCHOBER, ANNE signed 2016-02-28
KLEIN, CHRISTIAN signed 2016-02-29
MOESSNER, EKKEHARD signed 2016-02-22
MOSER, SAMUEL signed 2016-02-23
UMANA, PABLO signed 2016-02-29
WEINZIERL, TINA signed 2016-02-15
ROCHE GLYCART AG SCHLIEREN67091/357PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.